Azenosertib in Uterine Serous Carcinoma: Biomarker Study

Conditions: Uterine Serous Carcinoma; Uterine Carcinoma; Uterine Cancer Interventions: Drug: Azenosertib Sponsors: Joyce Liu, MD; National Cancer Institute (NCI); Zentalis Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials